Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
JBMR Plus|May 3, 2019
Overexpression of WNT16 Does Not Prevent Cortical Bone Loss Due to Glucocorticoid Treatment in MiceImranul Alam, Dana K Oakes, Austin M Reilly, et al.
Bone|November 7, 2016
Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human diseaseImranul Alam, Amie K McQueen, Dena Acton, et al.
Endocrinology|November 20, 2015
Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in MiceImranul Alam, Mohammed Alkhouli, Rita L Gerard-O'Riley, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 12, 2022
Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in miceImranul Alam, Rita L Gerard-O'Riley, Dena Acton, et al.
Calcified Tissue International|May 11, 2024
Effect of Allele-Specific Clcn7<sup>G213R</sup> siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S BackgroundSuzanne Saffie-Siebert, Imranul Alam, Flavia Maria Sutera, et al.
Calcified Tissue International|December 26, 2016
Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in OsteocytesImranul Alam, Austin M Reilly, Mohammed Alkhouli, et al.
Pageof 2